This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In doing so it’s compounded pre-existing pressure with pharma, where schedules are shrinking and policies are often already restrictive enough to build barriers for effective physician engagement. The threat of disease spread and other risk factors from COVID-19 have only compounded this.
Coming Soon: ASBM/GaBI Webinar on IRA’s Medicare Price Negotiation Provisions ASBM and the Generics and Biosimilars Initiative (GaBI) are in the final planning stages for the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA).
On November 1, 2023, long-awaited revisions to the United States Pharmacopeia (USP) Chapters <795>: Pharmaceutical Compounding – Nonsterile Preparations and <797>: Pharmaceutical Compounding – Sterile Preparations became official. Chapters <795> and <797> present the standards for preparing compounded medications.
While the market was worth over $6 billion in 2012, this has now grown to nearly $48 billion only a decade later, said Avigayil Chalk, PhD, GlobalData’s Senior Oncology and Haematology analyst, at an immuno-oncology webinar held on May 23. This high compound annual growth rate of 23.6%
HEAL Health recently organised a webinar titled ‘Demystifying the NMC Guidelines Conundrum’ against the backdrop of the recent postponement of the National Medical Commission (NMC) guidelines. The insights that emerged encompassed a spectrum of perspectives, shedding light on intricate challenges and potential solutions.
Coming Soon: ASBM/GaBI Webinar on IRA’s Medicare Price Negotiation Provisions ASBM and the Generics and Biosimilars Initiative (GaBI) are in the final planning stages for the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA).
Watch It Now The post FIP TREATMENT IN THE USA: Compounded GS-441524 tablets are now available! Get the most up-to-date information on treatment and monitoring protocols for FIP that are being routinely utilized in Australia, the UK and Japan – and how you can now confidently treat cases in the US!
Watch It Now The post FIP TREATMENT IN THE USA: Compounded GS-441524 tablets are now available! Get the most up-to-date information on treatment and monitoring protocols for FIP that are being routinely utilized in Australia, the UK and Japan – and how you can now confidently treat cases in the US!
My first job here with Stokes was as a sales rep selling human compounded medication. There’s still a lack of understanding of the difference between a 503A traditional compounding pharmacy versus a 503B outsourcing facility. Going into compounding was challenging because compounding is different than traditional retail.
That requirement is often a key point in litigation when a patent claims a class of novel compounds or antibodies. In this day-after webinar, litigators from Goodwin’s Supreme Court and IP Litigation practices will recap the argument and explain what it could mean for the future of the enablement requirement.
Some takeaways on those efforts that we gleaned from the report: Compounding. OC devoted a lot of resources to its compliance efforts directed at human drug compounding. Communication in this area included on-line videos, webinars, summits, conferences, and international outreach. Drug Supply Chain.
The FDA recently finalized regulatory guidance for compounded animal medications from bulk drug substances for use in non-food-producing animals, impacting the way compounded drugs can be used, documented, ordered, and prescribed. Bulk drug substances are the raw active ingredients most compounded medications are made from.
Implementation of GFI #256 Earlier this year, the FDA finalized regulatory guidance for compounded medications, known as GFI #256. If GFI is affecting your practice’s ability to get compounded medications for office use, partnering with a trusted 503B outsourcing facility can help you eliminate risks of limited ordering.
Our sister division, Stokes Pharmacy, formed an exclusive partnership with the Bova Group to bring safe, compounded treatment for feline infectious peritonitis (FIP) to the US. Cat Owner FAQs Veterinary FIP Resources Our webinars, downloads, and other resources can help you treat FIP patients. Read the CVMs statement here. Norris, J.
At this stage, lead compounds will be ranked based on their activity in primary and secondary assays, demonstrating acceptable specificity and selectivity for the biological target that is proposed to be key for the desired therapeutic area. We start by using in-silico modeling of any pre-existing data associated with the lead compounds.
These can include both in-person trainings, live webinars, or home studies. 07 Compounding Activities related to sterile, nonsterile, and hazardous drug compounding for humans and animals. There are currently over 20 home study webinars to choose from on our website. ACPE defines 3 types of CPE activities : 1.
A recent pharmaphorum webinar on digital transformation , held in association with P360, explored how COVID has fast-tracked pharma’s long-held ambitions to make wider use of digital technology and streamline its communications with HCPs. Physician access issues coupled with message delivery disconnects only compounded the problem.
That’s where compounded medications have really made a difference for us in the shelters, such as compounded ponazuril or compounded doxycycline. Working for a municipal shelter, we had to create a contract where we’d have to establish a relationship with a compounder. We’d get a budget through a bid process.
I think that’s where there is so much room for education, not only on the difference between 503A and 503B, but the difference between traditional manufacturing and compounding. I think that a lot of times, practices look at compounded meds and consider them regular pharmaceuticals. Regulations are put in place for a reason.
We host several webinars on a variety of topics that our sales team and customers enjoy and learn from. There still is a knowledge gap of what 503B means to the veterinary industry and the differences between a compounding pharmacy and an outsourcing facility. Do you have any plans to create more education around that?
Nitrosamines’ emergence in drug products Nitrosamines are organic chemical compounds that may be present in low levels in a wide variety of products such as processed meats, cosmetics and cigarette smoke. When they are metabolized, they are converted to alkylating agents that can damage DNA and have been linked to cancer.
Ophthalmology Webinar Practical Corneal Ulcer Management for General DVMs Presented by Alex Sigmund, DVM, DACVO May 21 | 8 pm ET Register My Spot Has the comfortability with ophthalmology grown with more available education for both veterinarians and pet parents on social media?
This education can be delivered through various formats, such as webinars, videos, and written materials. This challenge is further compounded by varying levels of health literacy among patients, requiring pharma companies to communicate complex medical information in ways that are understandable to a broad audience.
When combined with the challenges of living with a disability, these individuals may encounter compounded discrimination and systemic biases. The stigma associated with a history of incarceration or interaction with the legal system can create significant barriers to employment, housing, and social services.
Our chemists and formulation scientists review the properties of new drug candidates and “work their magic” to develop formulations that improve the exposure profile of the compound. How does bioavailability play a role in biopharmaceutics? Now fraction absorbed and bioavailability are often confused and used interchangeably.
When it comes to highly sensitive large-molecule drugs, sourcing premium elastomeric components with a cleaner compound, such as Datwyler’s FM457, is an essential step in reducing the E&L risk. This on-demand webinar discusses the importance of a patient-appropriate BL & GF profile.
From alcohols to quaternary ammonium compounds, each type of agent has a unique mode of action, with varying degrees of efficacy. Later in the webinar, she also shares the results of a recent study investigating the efficacy of BKC against gram positive and gram negative bacteria and yeast. Is Benzalkonium Chloride a good choice?
Vitafoods India 2025 brings a host of exciting new features, including a Webinar on “Is the Nutraceuticals Industry Gaining Renewed Immunity with Sustainability?” per cent and a forecasted value of USD 12 billion by 2030. ” delving into the intersection of sustainability and industry growth.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content